Recovery Force LLC has received US Food and Drug Administration (FDA) 510(k) clearance for the use of the Movement and Compressions (MAC) System, a novel, data-driven, mobility measurement device designed for hospital and home use.
The company will commercially launch the MAC System in hospitals effective immediately, which will initiate the execution of a $1.8M NIH grant scheduled to kickoff at Eskenazi Hospital in Indianapolis, IN and Tufts Medical Center in Boston, according to Recovery Force Health — a subsidiary of Recovery Force LLC — in a media release.
The MAC System is designed to provide therapeutic compressions to the lower leg and display real-time patient mobility data, providing metrics to support the execution of in-hospital mobility and adherence to DVT prophylaxis.
Early patient mobility could combat non-reimbursable hospital-acquired events such as pneumonia (HAP), pressure ulcers, blood clots, and increased length-of-stay. The MAC System offers a solution that provides transparency and access to patient mobility data while fitting into the complicated hospital workflow.
“The Movement and Compressions System integrates the physiological benefits of typical intermittent pneumatic compression (IPC) into a low-profile wearable device free of cords, hoses, and disruptive pump noise.”
— Matthew Wyatt, President and CEO of Recovery Force
Additionally, MAC provides at-risk patients discharged to the home setting access to the same mobility and compression data to actively engage and participate in their recovery, per the release.
For more information, visit Recovery Force Health.
[Source(s): Recovery Force Health, PR Newswire]